FANCL saw the highest growth of 1.32% in patent filings in May and 5.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.59% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of FANCL‘s patent filings and grants. Buy the databook here.
FANCL has been focused on protecting inventions in Japan(JP) with 21 publications in Q2 2024
The Japan(JP) Patent Office dominates the patent filings and grants with nearly 82% filings and 100% grants. The Japan(JP), European Patent Office(EPO), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where FANCL is filings its patents. Among the top granted patent authorities, FANCL has 100% of its grants in Japan(JP).
Roche could be the strongest competitor for FANCL
Patents related to rare diseases and health & wellness lead FANCL's portfolio
FANCL has the highest number of patents in rare diseases followed by, health & wellness and healthtech. For rare diseases, nearly 33% of patents were filed and 38% of patents were granted in Q2 2024.
Cosmetics & toiletries related patents lead FANCL portfolio followed by skincare, and food
FANCL has highest number of patents in cosmetics & toiletries followed by skincare, food, oils and fats, and clothing & footwear. For cosmetics & toiletries, nearly 25% of patents were filed and 22% of patents were granted in Q2 2024.
For comprehensive analysis of FANCL's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.